CLOSE X

SCRP0202i

**Upon testing, the current lot of material did not meet WiCell’s standards for quality, and it is therefore unavailable. WiCell is working with the Provider to obtain replacement materials for distribution. To be notified of the status of this cell line please submit your information here.
Cell Line Alias KBET0202i
Cell Type Human iPS
Disease Coronary artery disease
Myocardial infarction
Diagnosis Information Diagnosis of Myocardial infarction and Coronary Artery disease were physician reported. Age at diagnosis was 40 years of age. Additional diagnosis of hypertension, hypercholesterolemia, and stroke were self-reported.
Genetic Alteration/Mutation Information Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites.
Sex Male
Age at Collection 49 Years
Ethnicity Caucasian > European
Ethnicity Information Ethnicity information was obtained by Sequenom Genotyping.
Genetically Related Cell Lines  
Reprogramming Method Non-Integrating (Episomal Plasmid: Oct4, Klf4, Sox2, L-Myc, shp53, Lin28)
Tissue Origin Blood
Provider The Scripps Research Institute - Dr. Eric Topol
dbGaP Data  
hPSCReg ID  
NIH Approval  
Pub Med Abstract  
Collection(s) NHLBI Next Gen - Coronary artery disease and myocardial infarction (Dr. Eric Topol, Scripps Research Institute)

Current Lot Information

Lot Number Culture Platform Lot Description Passage Number Banked By Protocol Product Information & Testing
DB42005 mTeSR1/Matrigel   18 Provider WiCell Feeder Independent Pluripotent Stem Cell Protocol PDF